Cartesian Therapeutics, Inc.
Descartes-08
myasthenia gravis
Countdown
358days
FDA decision · ~ Jun 30, 2027 estimated
What's at stake
The FDA's approval decision on Descartes-08 for myasthenia gravis is due ~ Jun 30, 2027. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“BLA filing planned for mid-2027”